Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of November 16th – 22th, 2020.

Without further ado, let’s get started.

* Yahoo Finance readers, please click here to view the full article.

10. As the Pandemic Rages On, This Psychedelics Firm is Taking a Unique Approach to Treat Mental Health

The 2020 Elections Brought Another Huge Win for Drug Reform Advocates as Cannabis was Legalized in Several New States, Oregon and Washington D.C. Legalized Medicinal Psilocybin, aka Magic Mushrooms

Field Trip Health FTRPF believes it has the right business plan, intellectual property (IP) and clinical infrastructure to develop blockbuster Psychedelic medicines. Perhaps most importantly, the company is led by a stacked lineup of successful business leaders and scientists.

READ FULL PSYCHEDELICS ARTICLE

9. Cannabis Earnings Roundup: Exceptional Growth Trend Continues for Top U.S. MSOs in Q3

Another Record-Breaking Cannabis Earnings Season is in the Books for the “Big 4” U.S. Multi-State Operators (MSOs)

Despite a global pandemic, American Cannabis Stocks are in the midst of a breakout year, with the nation’s largest cannabis operators leading the charge. Here is our Q3 2020 Earnings recap from the top 4 U.S. Multi-State Operators MSOs Trulieve Cannabis TCNNF, Curaleaf Holdings CURLF, Green Thumb Industries GTBIF and Cresco Labs CRLBF.

READ FULL MSOS EARNINGS ARTICLE

8. Psychedelic Drugs Are Fueling a Mental Health Revolution

Once Deemed Dangerous and Illegal, Psychedelic Drugs Have Been Rediscovered By the Scientific, Medical and Psychiatric Communities as Research Reveals Their Capacity to Help Patients with a Range of Maladies

With investors beginning to flood this new market with capital, will Big Pharma join in, or try to squash a nascent revolution of the mind?

READ FULL PSYCHEDELIC MEDICINE ARTICLE

7. Mexican Senate Passes Bill to Legalize Marijuana Nationwide

Mexico’s Senate Approved a Bill to Legalize Marijuana Nationally on Thursday

Before it can become law it must also be passed by the other body of the country’s Congress, the Chamber of Deputies. The legislation, which was circulated in draft form earlier this month, would establish a regulated cannabis market in Mexico, allowing adults 18 and older to purchase and possess up to 28 grams of marijuana and cultivate up to six plants for personal use.

READ FULL MEXICO ARTICLE

6. ‘The War on Drugs Failed’: California Lawmaker Will Push to Decriminalize Psychedelics

The Movement to Reform Drug Policy Celebrated a Number of Victories in the Recent Election, With Voters Across America Opting to Legalize Marijuana and Decriminalize Narcotics in an Unprecedented Overhaul

Now, a California lawmaker has announced he will take on the arduous battle to decriminalize psychedelics in the state, citing Oregon, which voted to decriminalize hard drugs and legalize Psilocybin, and the District of Columbia, which has decriminalized Psychedelics, as inspiration.

READ FULL CALIFORNIA PSYCHEDELICS ARTICLE

5. New Jersey Senate and Assembly Committee Pass Marijuana Sales Bills Despite Pushback From Equity Advocates

More than 2/3 of NJ Voters Passed a Referendum on Election Day to Legalize Cannabis for Adults, But State Lawmakers Still Have to Pass Legislation to Establish Rules for the New System Before Legal Sales Can Begin

Lawmakers in New Jersey advanced amended legislation on Thursday to enact a regulated marijuana market in the state, although new differences between Assembly and Senate versions of the proposal mean that further negotiations will be needed before anything can be enacted.

READ FULL NEW JERSEY CANNABIS ARTICLE

4. German Government Funds Psilocybin Study

Germany Has Approved a Large Phase 2b Study on Psilocybin for Treatment-Resistant Depression

Dr. Gerhard Gründer, of the Central Institute of Mental Health Mannheim, will lead the study alongside the Department of Psychiatry and Psychotherapy at Charité Campus Berlin Mitte and the Mind Foundation. The German Government is funding the trials with €2 million allocated from the Federal Ministry of Education and Research.

READ FULL GERMANY PSYCHEDELICS ARTICLE

3. A Right-Leaning Supreme Court Won’t Impede Cannabis Reform, Legal Experts Say

Cannabis Reform Likely Won’t Be One of Those Matters, Legal Experts Say

Under a month into the role, Justice Barrett stands poised to weigh in on a myriad of pressing issues, including voting rights, the census and the fourth amendment.

READ FULL SCOTUS CANNABIS ARTICLE

2. Psilocybin & Migraine: First of its Kind Trial Reports Promising Results

The Exploratory Study, Led By Researchers From Yale School of Medicine, Has Found a Single Dose of the Psychedelic Psilocybin Can Reduce Migraine Frequency By 50% for a Least Two Weeks

The preliminary trial was small, with follow-up work necessary to validate the results, but the promising findings suggest great potential for Psychedelics to treat migraines and cluster headaches.

READ FULL PSILOCYBIN ARTICLE

1. $6 Billion Question: Which States Are Likely to Legalize Recreational Marijuana in 2021?

Recreational Marijuana Legalization Victories at the Ballot Box in Arizona and New Jersey This Month Have Set the Table for Adult-Use Legalization in a Handful of Nearby States in 2021

With more than $6 billion in business opportunities possibly up for grabs within a few years. “New York, Connecticut, Maryland, New Mexico are ripe for 2021” to legalize recreational use through their legislatures, said Steve Hawkins, executive director of the Washington DC-based Marijuana Policy Project.

READ FULL CANNABIS 2021 ARTICLE

Photo by Jakub Matyáš on Unsplash